Investment Centers of America’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-22,318
Closed -$1.8M 170
2017
Q3
$1.8M Sell
22,318
-3,081
-12% -$236K 0.13% 151
2017
Q2
$1.79M Sell
25,399
-3,665
-13% -$244K 0.14% 151
2017
Q1
$1.98M Buy
29,064
+1,958
+7% +$138K 0.15% 136
2016
Q4
$1.93M Buy
27,106
+2,716
+11% +$202K 0.16% 134
2016
Q3
$1.94M Buy
24,390
+1,982
+9% +$161K 0.2% 113
2016
Q2
$1.87M Buy
22,408
+1,674
+8% +$149K 0.21% 111
2016
Q1
$1.9M Buy
20,734
+3,225
+18% +$291K 0.21% 114
2015
Q4
$1.77M Buy
17,509
+1,688
+11% +$176K 0.23% 110
2015
Q3
$1.56M Buy
15,821
+5,247
+50% +$583K 0.24% 111
2015
Q2
$1.24M Sell
10,574
-25
-0.2% -$2.73K 0.19% 141
2015
Q1
$1.05M Buy
10,599
+2,145
+25% +$218K 0.15% 152
2014
Q4
$789K Buy
8,454
+266
+3% +$27.5K 0.17% 141
2014
Q3
$874K Sell
8,188
-3,720
-31% -$364K 0.16% 148
2014
Q2
$982K Buy
11,908
+8,197
+221% +$638K 0.22% 118
2014
Q1
$234K Buy
3,711
+303
+9% +$23.8K 0.05% 314
2013
Q4
$215K Sell
3,408
-303
-8% -$21.1K 0.1% 213
2013
Q3
$234K Buy
+3,711
New +$222K 0.05% 318

Other funds holding GILD

Investment Centers of America's GILD Position: Q4 2017 in Review

Investment Centers of America sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 22,318 shares — an estimated $1.8M sold.

Investment Centers of America first reported a position in GILD in Q3 2013 and held it in 17 quarters. The position peaked at $1.98M in Q1 2017. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Investment Centers of America reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 22,318 Gilead Sciences shares in Q4 2017, an estimated $1.8M.
  • Investment Centers of America first reported a position in Gilead Sciences in Q3 2013 and held it in 17 quarters.
  • Investment Centers of America's Gilead Sciences position peaked at $1.98M in Q1 2017.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.